ArticlePloS one2024

Correction: An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.

Qing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.